Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | China | 07 Mar 2025 | |
Acute Myeloid Leukemia | Phase 1 | China | 07 Mar 2025 | |
Chronic Lymphocytic Leukemia | Phase 1 | China | 07 Mar 2025 | |
Chronic Myelogenous Leukemia | Phase 1 | China | 07 Mar 2025 |